PEG-urate oxidase conjugates and use thereof
First Claim
Patent Images
1. A method for isolating a tetrameric form of uricase from a solution of purified uricase, said purified uricase comprising tetrameric uricase and uricase aggregates, said method comprising:
- separating the solution into fractions on at least one separation column at a pH of 9 to 10.5, wherein said column is selected from the group consisting of an ion-exchange column and a size-exclusion column; and
recovering from said column one or more fractions that contain isolated tetrameric uricase, wherein said one or more fractions contain less than 10% of uricase aggregates larger than tetramers.
12 Assignments
0 Petitions
Accused Products
Abstract
A naturally occurring or recombinant urate oxidase (uricase) covalently coupled to poly(ethylene glycol) or poly(ethylene oxide) (both referred to as PEG), wherein an average of 2 to 10 strands of PEG are conjugated to each uricase subunit and the PEG has an average molecular weight between about 5 kDa and 100 kDa. The resulting PEG-uricase conjugates are substantially non-immunogenic and retain at least 75% of the uricolytic activity of the unmodified enzyme.
55 Citations
6 Claims
-
1. A method for isolating a tetrameric form of uricase from a solution of purified uricase, said purified uricase comprising tetrameric uricase and uricase aggregates, said method comprising:
-
separating the solution into fractions on at least one separation column at a pH of 9 to 10.5, wherein said column is selected from the group consisting of an ion-exchange column and a size-exclusion column; and recovering from said column one or more fractions that contain isolated tetrameric uricase, wherein said one or more fractions contain less than 10% of uricase aggregates larger than tetramers. - View Dependent Claims (2, 3, 4, 5, 6)
-
Specification